Craig M. Potteiger

Statistics

Publications

Citations

225

H-Index

Active since

2008

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Craig M. Potteiger is an author at United States Military Academy specializing in pharmacology, medicinal chemistry, and calcitonin gene-related peptide antagonists.

Publications per year

2008–2018

Publications

Synthesis of the (3<i>R</i>,6<i>S</i>)-3-Amino-6-(2,3-difluorophenyl)azepan-2-one of Telcagepant (MK-0974), a Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine Headache

Christopher S. Burgey, Daniel V. Paone, Anthony W. Shaw et al. · Organic Letters · 2008 · 61 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Imidazopyridine CB2 agonists: Optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacy

B. Wesley Trotter, Kausik K. Nanda, Christopher S. Burgey et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 59 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Expanding the scope of the Cu assisted Suzuki–Miyaura reaction

Brendan M. Crowley, Craig M. Potteiger, James Z. Deng et al. · Tetrahedron Letters · 2011 · 27 citations

Natural Sciences, Chemistry, Catalysis +7

Novel oxazolidinone calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraine

Brendan M. Crowley, Craig A. Stump, Diem N. Nguyen et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 26 citations

Medicine, Pharmacology, Pharmacotherapy +12

Optimization of azepanone calcitonin gene-related peptide (CGRP) receptor antagonists: Development of novel spiropiperidines

Christopher S. Burgey, Craig M. Potteiger, James Z. Deng et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–5 of 7